AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12094846
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg and 20 mg
Trial: 7724891
Drug: Morphine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 2.5 mg i.v. on‐demand (Group 1)
Trial: 7724891
Drug: Clonixin 400
RxNorm normalized name: clonixin
DrugBank: Clonixin (DB09218)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonixin 400 mg/day i.v. infusion (Group 2)
Trial: 7724891
Drug: Morphine 0.4
RxNorm normalized name: morphine 0.4 mg/mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.4 mg/kg/day i.v. infusion (Group 3)
Trial: 7724891
Drug: Clonixin 400
RxNorm normalized name: clonixin
DrugBank: Clonixin (DB09218)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonixin 400 mg/day plus morphine 0.4 mg/kg/day i.v. infusion (Group 4)
Trial: 6772386
Drug: Diltiazem, 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem, 240 mg daily dose
Trial: 27530339
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml of autologous bone marrow cells (BMCs) by local intramuscular application (n=32)
Trial: 27530339
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml of autologous bone marrow cells (BMCs) by intra-arterial application (n=30)
Trial: 24383962
Drug: amikacin/fosfomycin (300/120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amikacin/fosfomycin (300/120 mg combination)
Trial: 15447697
Drug: Riboflavin 400
RxNorm normalized name: riboflavin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riboflavin 400 mg, Magnesium 300 mg, Feverfew 100 mg
Trial: 15447697
Drug: Placebo (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (25 mg riboflavin)
Trial: 11240597
Drug: IM Fosphenytoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM Fosphenytoin (10 mg/kg)
Trial: 11240597
Drug: IM Saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM Saline (up to 19.5 mL or 2 mL)
Trial: 9855446
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of influenza vaccine
Trial: 9855446
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of influenza vaccine (1994-1995 season)
Trial: 7863247
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg daily a.m.)
Trial: 7863247
Drug: Nizatidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine (300 mg twice daily)
Trial: 28961465
Drug: Pembrolizumab (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab (both doses)
Trial: 17700646
Drug: E2 (1
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E2 (1 mg/day for 1 month, then 2 mg/day for 2 months)
Trial: 16484769
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 mug once daily
Trial: 10697374
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid composition (100 mg 3 times a day sublingually)
Trial: 10697374
Drug: Preductal (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preductal (20 mg 3 times a day)
Trial: 31291793
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg lipoic acid (LA) once daily for 12 weeks
Trial: 16082837
Drug: Infusion therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion therapy including solutions of colloids and crystalloids (n=43)
Trial: 12584787
Drug: Folium Ginkgo
RxNorm normalized name: Ginkgo folium
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folium Ginkgo extract (FGE) 15 mg/kg.d for 7-8 days
Trial: 10721681
Drug: Citalopram (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (20 to 30 mg per day)
Trial: 10721681
Drug: Citalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10 to 15 mg per day)
Trial: 10721681
Drug: Citalopram (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (40 to 60 mg per day)
Trial: 10721681
Drug: Clomipramine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (60 to 90 mg per day)
Trial: 1493669
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg three times/day)
Trial: 4014126
Drug: Stepped Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped Care (intensive treatment group)
Trial: 10552979
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg), Amoxycillin (1 g), Metronidazole (400 mg) bd for 7 days (OAM)
Trial: 10552979
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg), Clarithromycin (250 mg), Metronidazole (400 mg) bd for 7 days (OCM)
Trial: 29310119
Drug: Amoxicillin 250
RxNorm normalized name: amoxicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 250 mg b.i.d. (group B; experimental)
Trial: 29310119
Drug: Amoxicillin 750
RxNorm normalized name: amoxicillin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 750 mg b.i.d. (group A; conventional)
Trial: 23342765
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBO2) combined with drugs
Trial: 16286100
Drug: Hydration and
RxNorm normalized name: Blistex Enhancement Series (Ultra-Rich Hydration and Lip Vibrance) KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydration and tenoxicam (20 mg orally once daily)
Trial: 2228650
Drug: 10 units
RxNorm normalized name: Omnipod GO 10 Units/Day Pods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 units of heparin in 1 ml sodium chloride solution
Trial: 30948522
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of levobupivacaine [0.125%] bolus delivered every 2 hours (n=20)
Trial: 30948522
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of levobupivacaine [0.125%] (6 mL/hour) (n=20)
Trial: 30948522
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of levobupivacaine [0.125%]
Trial: 30948522
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of levobupivacaine [0.125%]
Trial: 26386766
Drug: RenalGuard group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RenalGuard group (hydration with normal saline solution controlled by the RenalGuard system and furosemide)
Trial: 26386766
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal saline solution)
Trial: 21315352
Drug: Metoprolol CR/XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR/XL (25mg once daily)
Trial: 15567796
Drug: Ropivacaine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 20 ml (group R, n=33)
Trial: 11046100
Drug: HOE 140
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 140 (bradykinin B(2) receptor antagonist)
Trial: 11046100
Drug: Furosemide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (0.5 mg/kg i.v.)
Trial: 8407392
Drug: Hyperfractionated radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiotherapy at 75.6 Gy (1.26 Gy twice daily for 6 weeks)
Trial: 2944668
Drug: Constant SC
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant SC infusion of ICI 118630
Trial: 2944668
Drug: Monthly SC
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly SC slow-release depot formulation of ICI 118630
Trial: 31128948
Drug: Interval cytoreductive
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin
Trial: 31128948
Drug: Interval cytoreductive
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interval cytoreductive surgery without hyperthermic intraperitoneal chemotherapy (HIPEC)
Trial: 18379802
Drug: Bio-resorbable implant
RxNorm normalized name: Bio-Kool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-resorbable implant (Reunite osteosynthesis plate by Biomet Inc)
Trial: 18379802
Drug: Metal implant
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metal implant
Trial: 18379802
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (bio-resorbable and metal implants)
Trial: 10189654
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine sulphate (0.15 mg.kg‐1)
Trial: 10189654
Drug: Codeine phosphate
RxNorm normalized name: Codeine Phosphate
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine phosphate (1.5 mg.kg‐1)
Trial: 31584939
Drug: Maternal nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal nutrition intervention (nutrition counseling and micronutrient supplements)
Trial: 23384077
Drug: Lower alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lower alcohol dose group (mean BAC 0.04%, N = 40)
Trial: 23384077
Drug: Higher alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher alcohol dose group (mean BAC 0.06%, N = 44)
Trial: 18056792
Drug: 20% Intralipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% Intralipid infusion [0.7 ml.kg(‐1).h(‐1) (1.54 g/kg)] for 11 h
Trial: 18056792
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline infusion for 11 h (control)
Trial: 12195603
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 micro g once daily
Trial: 12728159
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 micro g twice daily
Trial: 11590493
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (PI plus two nucleosides)
Trial: 11590493
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (PI plus one nucleoside)
Trial: 9305714
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (8 cycles)
Trial: 9305714
Drug: Chemotherapy (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (6 cycles) plus radiation therapy
Trial: 8371918
Drug: Apraclonidine 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apraclonidine 0.5% (3 times daily)
Trial: 8371918
Drug: Apraclonidine 0.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apraclonidine 0.25% (3 times daily)
Trial: 29914095
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD) of Ecologic® Barrier (1 × 10^10 CFU per day)
Trial: 29914095
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (LD) of Ecologic® Barrier (2.5 × 10^8 CFU per day)
Trial: 27893675
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg TUDCA plus UDCA placebo
Trial: 27893675
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg UDCA plus TUDCA placebo
Trial: 21993405
Drug: Dose response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dose response modelling
Trial: 20070758
Drug: Single ball-type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single ball-type mini-implants (Group I)
Trial: 20070758
Drug: Mini-implants splinted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini-implants splinted with a prefabricated bar (Group II)
Trial: 19000365
Drug: MDI (Metered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI (Metered Dose Inhaler)
Trial: 16186088
Drug: Behavioral drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral drug abuse therapies
Trial: 10571351
Drug: Laser trabeculoplasty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser trabeculoplasty and topical betaxolol twice daily in eligible eyes
Trial: 10571351
Drug: No initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No initial treatment with close follow-up
Trial: 9339040
Drug: Scleral and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scleral and corneal tunnel incisions (6.0‐mm W; 3.5‐ and 2.5‐mm L scleral tunnel; 4.1‐mm linear and 2.5‐mm L corneal tunnel)
Trial: 2643357
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment plus a fixed schedule of nicotine gum
Trial: 2643357
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment plus an ad lib schedule
Trial: 1259398
Drug: Oxolinic acid
RxNorm normalized name: oxolinic acid
DrugBank: Oxolinic acid (DB13627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxolinic acid (1.5 g twice daily by mouth for 5 to 12 days)
Trial: 1259398
Drug: Amoxicillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (3 patients responded to this treatment)
Trial: 26100002
Drug: HP gel
RxNorm normalized name: HP 502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HP gel + KTP laser irradiation
Trial: 26100002
Drug: HP gel
RxNorm normalized name: HP 502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HP gel + Er:YAG irradiation
Trial: 26100002
Drug: HP gel
RxNorm normalized name: HP 502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HP gel without laser irradiation
Trial: 23330721
Drug: 14-bp insertion/deletion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-bp insertion/deletion polymorphism of HLA-G gene (dominant model)
Trial: 23330721
Drug: 14-bp insertion/deletion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-bp insertion/deletion polymorphism of HLA-G gene (codominant model)
Trial: 23330721
Drug: 14-bp insertion/deletion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-bp insertion/deletion polymorphism of HLA-G gene (dominant model after sensitivity analysis)
Trial: 23330721
Drug: 14-bp insertion/deletion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-bp insertion/deletion polymorphism of HLA-G gene (codominant model after sensitivity analysis)
Trial: 2492597
Drug: Human milk
RxNorm normalized name: HUMAN MILK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human milk preparation (14 mL/kg/d for 2 weeks)
Trial: 2492597
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water (14 mL/kg/d for 2 weeks)
Trial: 29927279
Drug: Both DT
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both DT and ST treatments included transdermal nicotine patch and structured sessions.
Trial: 19164205
Drug: Erlotinib 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 300 mg
Trial: 17364629
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of superactivated charcoal (50 g)
Trial: 17364629
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of superactivated charcoal (50 g, six doses q4h)
Trial: 11075558
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion (TCI) group
Trial: 11075558
Drug: Conventional continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional continuous infusion (Cont group)
Trial: 1300957
Drug: rt PA
RxNorm normalized name: ATTENDS INSERT PAD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt PA (10 mg bolus followed by 90 mg in 130 mn)
Trial: 3840066
Drug: Acrivastine (BW825C)
RxNorm normalized name: Acrivastine
DrugBank: Acrivastine (DB09488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acrivastine (BW825C) 4 mg, 8 mg, and 16 mg
Trial: 3840066
Drug: Triprolidine HCl
RxNorm normalized name: Triprolidine HCl
DrugBank: Triprolidine (DB00427)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triprolidine HCl 2.5 mg and 5 mg
Trial: 30648677
Drug: GA +
RxNorm normalized name: Sea-Omega + D Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA + intravenous analgesia (Group II)
Trial: 30098042
Drug: Pimodivir 600
RxNorm normalized name: Pimodivir
DrugBank: Pimodivir (DB14974)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimodivir 600 mg with oseltamivir 75 mg
Trial: 24874893
Drug: Adalimumab (dose-escalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab (dose-escalation subcohort)
Trial: 20598967
Drug: Prasugrel +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel + aspirin
Trial: 15818103
Drug: Low tidal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low tidal volume ventilation (6 mL/kg of predicted body weight)
Trial: 15818103
Drug: Higher tidal
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher tidal volume ventilation (12 mL/kg of predicted body weight)
Trial: 7634133
Drug: Delmopinol hydrochloride
RxNorm normalized name: delmopinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delmopinol hydrochloride solution (2 mg/ml) rinsing for 60 s twice daily
Trial: 2792175
Drug: digoxin and
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: digoxin and concomitant treatment with urapidil 60 mg b.d.
Trial: 2792175
Drug: digoxin monotherapy
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: digoxin monotherapy
Trial: 356508
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam combined with intramuscular administration of vehicle used in Group B (Group C)
Trial: 22261128
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1 capsule daily for 3 months)
Trial: 20039078
Drug: Ketamine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1.0 mg kg(‐1)
Trial: 16353968
Drug: Gelled self-emulsifying
RxNorm normalized name: marine non-gelling gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelled self-emulsifying formulation (SEF) containing ketoprofen (KPF)
Trial: 16353968
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release solid dosage form
Trial: 12559482
Drug: Low-dose physostigmine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose physostigmine (PHYSO) 8 microg/kg IV
Trial: 2480243
Drug: Streptozocin plus
RxNorm normalized name: Streptozocin
DrugBank: Streptozocin (DB00428)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Streptozocin plus 5‐fluorouracil (chemotherapy)
Trial: 229780
Drug: Total Parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Parenteral Nutrition (TPN) for 28 days
Trial: 229780
Drug: Total Parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Parenteral Nutrition (TPN) for less than 9-14 days
Trial: 229780
Drug: Intensive Nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive Nutritional Counseling (INC) and oral supplementation
Trial: 30994576
Drug: Vaginal 10
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal 10 μg estradiol tablet plus placebo gel (n = 102)
Trial: 30994576
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet plus vaginal moisturizer (n = 100)
Trial: 28341129
Drug: Hand washing
RxNorm normalized name: ALCOHOL 350 mL in 500 mL EXTRACORPOREAL GEL [75% alcohol free hand washing gel]
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand washing with alcohol gel only up to elbows (Group A)